Digital prevention for liver disease management

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD) and its severe form, metabolic dysfunction-associated steatohepatitis (MASH). It aims to develop a new model of care that combines standard clinical procedures with a digital approach, utilizing a mobile application for patients and a clinical dashboard for healthcare professionals. The study will collect and analyze clinical data, including anthropometric, laboratory, and imaging data, to enhance early detection and management of MASLD. The goal is to improve patient outcomes through better monitoring and support.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with MASLD and LSM\>= 10 kPa
* Age \>= 18 years old
* Sufficient digital literacy or supported from a caregiver with sufficient digital literacy
* Smartphone (Android or iOS) able to download and run the App
* Able to understand and communicate in Italian
* Able to sign the informed consent

Exclusion Criteria:

* Major psychiatric disorder
* Not able to use digital technologies

Where it's running

• Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Medicina Trapianti Fegato and UOC CEMAD
  Rome, Lazio, Italy Recruiting

Study contacts

• Principal investigator: Luca Miele — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
• Study coordinator: Luca Miele
• Email: luca.miele@policlinicogemelli.it
• Phone: +390630155701

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Digoxin for NASH with stage 2–3 fibrosis

  This trial will see if taking once-daily digoxin helps clear NASH and reduce liver scarring in adults with biopsy-confirmed NASH and stage 2–3 fibrosis.

  Recruiting at 2 sites Phase 2 Yale University · New Haven, Connecticut and 1 other locations · NCT06588699

• Very low-calorie ketogenic diet for patients with liver disease

  This study is testing whether a very low-calorie ketogenic diet can improve liver health and help with weight management in people with liver disease compared to a standard low-calorie Mediterranean diet.

  Recruiting University of Bologna · Bologna · NCT06308757

• Investigating how androgens affect liver health in young women

  This study is trying to see how hormones called androgens affect liver health in young women, especially those with polycystic ovary syndrome, by comparing liver disease progression between women with and without this condition.

  Recruiting University of California, San Francisco · San Francisco, California and 1 other locations · NCT06124261

• A registry for studying Non-Alcoholic Fatty Liver Disease in Europe

  This study is collecting health information and samples from people with Non-Alcoholic Fatty Liver Disease to learn more about the disease and find better ways to track its progress.

  Recruiting at 33 sites Newcastle University · Antwerp and 36 other locations · NCT04442334

• Non-invasive blood and imaging tests for metabolic liver disease

  This project tests whether blood tests and imaging scans can diagnose and stage metabolic-associated steatohepatitis (MASH) and liver fibrosis in adults with metabolic risk factors.

  Recruiting at 4 sites Foundation for the National Institutes of Health · Miami, Florida and 3 other locations · NCT07122700

• Low‑methoxy pectin for inflammation, gut microbiome, and metabolic health in MASLD

  This tests whether taking daily low‑methoxy pectin for six weeks can reduce inflammation and improve gut bacteria and metabolic markers in adults with MASLD.

  Recruiting at 3 sites University of Nottingham · Nottingham, United Kingdom and 2 other locations · NCT07093346

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.